Dan Bryson

Dan Bryson has extensive experience in finance, currently serving as Executive Director of Finance at Neurocrine Biosciences since October 2017, having previously held the position of Senior Director of Finance at the same company. Prior to this role, Dan served as Senior Director of Finance at Otonomy, Inc. from May 2014 to October 2017, and as Director of Financial Reporting at Santarus, Inc. from April 2011 to April 2014. Dan's earlier career includes positions as Controller at La Jolla Pharmaceutical Company and Audit Manager at KPMG US. Dan earned a Bachelor of Arts degree in Economics and Anthropology from UC San Diego.